About Index Trending news
Analyze
Top 50 Pricing
Esperion Therapeutics

Esperion Therapeutics

Work at Esperion Therapeutics? Add yourself to this profile

Esperion Therapeutics

Esperion Therapeutics discovers and develops pharmaceutical products for the treatment of cardiovascular and metabolic diseases.

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding Show all
Post-IPO equity
$189,900,000
Venture capital
$33,000,000
Employees

Team size

10+

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Esperion Therapeutics makes some noise.